About us Newsletter News Widget Media Inquiries

Media Inquiries

Your experience will be better in the app

Install

Sign Up | Log In

Menu

Contact Us Terms of Service Support Privacy Policy Archive

© 2024 Otherweb

Subscribe to our newsletter

Everything you need to know about today's news — in your inbox each morning.

It’s free

By continuing, you agree to Otherweb's Terms of Service and acknowledge you've read our Privacy Policy

Follow

Featured Podcast EpisodesThe Other Web

Alex Fink

Zuckerman vs Zuckerberg

July 14, 2024

Ethan Zuckerman is a professor at the University of Massachusetts Amherst and a scholar of digital media. He and his team work to understand the contemporary digital world and build social media systems that are focused on communities, not on profits. Ethan is currently suing Meta (i.e. Facebook) in a landmark case that might (and likely should) change our interpretation of section 230. Please tune in to hear the details of the case and the various ways it could change the social media landscape. It's fascinating!

Prof. Jeff Jarvis - Rewriting Media's Business Model (Yet Again)

May 24, 2024

Jeff Jarvis is a journalism professor at the City College in New York (CUNY), the author of six books, and the cohost of the successful podcast "This week in Google and AI". Jeff spent many years teaching entrepreneurial journalism - and God knows journalism could use some entrepreneurial spirit, right about now. Please check out Jeff's books, The Gutenberg Parenthesis and Magazine, both from Bloomsbury (discount codes here: gutenbergparenthesis.com).

Donald Robertson - Where Philosophy Meets Psychology

June 22, 2024

Our guest today is Donald Robertson - Donald is a cognitive-behavioral psychotherapist and author of several books, including How to Think Like a Roman Emperor and, more recently, Marcus Aurelius: The Stoic Emperor. He is one of the founders of the Modern Stoicism nonprofit organization and the founder and president of the Plato's Academy Centre in Athens, Greece. He was born in Scotland but now lives in Montreal, Canada. His upcoming book, How to Think Like Socrates, will be released later this year, and can be preordered on Amazon, Barnes and Noble, or anywhere else books are generally sold.

Rick Edmonds - Analyzing the Financial Decline of Legacy Media

July 8, 2024

Rick Edmonds is the media business analyst for the Poynter Institute, a school and study center for working journalists. He has been doing research and writing for 25 years on the financial decline of legacy media, newspapers particularly, and the rise of new media alternatives. His reporting and commentary appear regularly on the Poynter Online site. He has spoken to conference groups in the U.S.A. and in Paris, Norway, Madrid, Vienna and Chile.

Jonathan Green - How To Make ChatGPT and Other Tools Useful (Right Now)

July 5, 2024

Welcome to the Otherweb. Our guest today is Jonathan Green - a bestselling author of hundreds of books, a celebrity ghostwriter, and an expert in using artificial intelligence tools to their utmost capacity. This is the best conversation I've had on the practical implications of ChatGPT and how regular people can augment their own capabilities by using these tools as a shortcut.

1h 4m

News from AstraZeneca

Stay current with all the latest and breaking news about AstraZeneca, compare headlines and perspectives between news sources on stories happening today. In total, 8 stories have been published about AstraZeneca which Ground News has aggregated in the past 3 months.

Recent news

Guardian

Guardian

AstraZeneca ‘said it could cut UK jobs’ if biodiversity drug levy is introduced

Guardian

View summary

Reuters

Reuters

AstraZeneca signs $1.92 billion licencing deal with HK-listed CSPC

Reuters

View summary

Telegraph

Telegraph

Boris Johnson: I planned to invade the Netherlands during Covid

Telegraph

View summary

Latest news stories

Reuters

Reuters

AstraZeneca in AI collaboration with Immunai to inform cancer drug trials

Reuters

View summary

Sky News

Sky News

AI technology can detect early signs of over 1,000 diseases, say researchers

Sky News

View summary

Reuters

Reuters

AstraZeneca says lung cancer drug trial shows no significant improvement in overall survival

Reuters

View summary

CNBC

CNBC

AstraZeneca says staff detained in China amid reports of a drug-import investigation

CNBC

View summary

Reuters

Reuters

AstraZeneca's Imfinzi gets FDA priority review for type of lung cancer

Reuters

View summary